MINOPHAGEN PHARMACEUTICAL CO L has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TECNOFARMACI SPA, S1 PHARMACEUTICALS INC and IDEA INNOVAT DERMALE APPL GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Ishiguro Akiko | 4 |
#2 | Utsunomiya Tokuichiro | 4 |
#3 | Kobayashi Makiko | 4 |
#4 | Sato Toshitsugu | 4 |
#5 | Takeda Midori | 4 |
#6 | Suzuki Fujio | 4 |
#7 | Iwata Shigemi | 4 |
#8 | Hamada Yuji | 4 |
#9 | Matsumoto Hiroatsu | 4 |
#10 | Okamura Chieko | 2 |
Publication | Filing date | Title |
---|---|---|
WO2007000967A1 | Remedy for cerebral infarction | |
EP1779854A1 | Glycyrrhizin-containing suppository compositions for rectal infusion | |
CN1980679A | Glycyrrhizin-containing suppository compositions for rectal infusion | |
AU2003300550A1 | Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients | |
AU2003288987A1 | Oil/glycyrrhizin-containing surfactant phase type gel composition |